Clinical trial

HeartMate 3 CE Mark Study Long Term Follow-up

NCT03022461

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2014-06-23

PhaseN/A

Study timeline

Study start (actual)2014-06-23Date precision: day

Registry last updated2022-06-27

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Advanced Refractory Left Ventricular Heart Failureunresolved

Interventions

Long term follow-upOTHER

Sponsors & collaborators

Abbott Medical Deviceslead sponsor

Mapped research locations

TorontoOntario, Canada1 BerlinGermany1 PragueCzechia1 ViennaAustria1 MelbourneVictoria, Australia1 HanoverGermany1 Freiburg im BreisgauGermany1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03022461 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.